Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation. [electronic resource]
Producer: 20191231Description: 110-117 p. digitalISSN:- 1029-2403
- Adolescent
- Adult
- Aged
- Clinical Decision-Making -- methods
- Drug Administration Schedule
- Epstein-Barr Virus Infections -- epidemiology
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Herpesvirus 4, Human -- drug effects
- Humans
- Lymphoproliferative Disorders -- mortality
- Male
- Middle Aged
- Models, Biological
- Patient Selection
- Retrospective Studies
- Risk Factors
- Rituximab -- administration & dosage
- Survival Analysis
- Transplantation, Homologous -- adverse effects
- Treatment Outcome
- Viral Load -- drug effects
- Viremia -- epidemiology
- Virus Activation -- drug effects
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.